Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.

Generic Drugs Need Government Support, House Health Subcommittee Admits

Generic Drugs Need Government Support, House Health Subcommittee Admits

U.S. based generic drug makers need government support to expand – and maybe even to survive – the onslaught of imports nearly every member of the House Energy and Commerce Committee Subcommittee on Health said in a hearing on Wednesday.

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

A smart policy like the ‘PILLS Act’ would prioritize domestic production of essential generics. It’s precisely the market signal needed to attract serious investment and rebuild the industry at home.

CPA Releases Comments on Section 232 Investigation of Pharmaceutical Imports

CPA Releases Comments on Section 232 Investigation of Pharmaceutical Imports

As the leading organization advocating for reshoring the generic drug industry, CPA’s submission documents how extreme overreliance on foreign pharmaceutical supplies—especially active pharmaceutical ingredients (APIs) and critical injectable drugs from China and India—poses an urgent threat to U.S. national security and patient safety.

America’s generic drug crisis demands investment, not dependence

America’s Generic Drug Crisis Demands Investment, Not Dependence

The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.